Citadel Advisors’s Nano X Imaging NNOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4K Buy
+14,119
New +$26.6K ﹤0.01% 13441
2025
Q4
Sell
-78,169
Closed -$281K 13624
2025
Q3
$289K Buy
+78,169
New +$348K ﹤0.01% 10460
2024
Q2
Sell
-2,192
Closed -$19.5K 15025
2024
Q1
$21.4K Sell
2,192
-72,546
-97% -$581K ﹤0.01% 12966
2023
Q4
$476K Sell
74,738
-121,227
-62% -$757K ﹤0.01% 8219
2023
Q3
$1.29M Buy
195,965
+184,806
+1,656% +$1.9M ﹤0.01% 6064
2023
Q2
$173K Buy
+11,159
New +$155K ﹤0.01% 10108
2021
Q4
Sell
-33,974
Closed -$704K 14435
2021
Q3
$764K Sell
33,974
-10,588
-24% -$278K ﹤0.01% 8834
2021
Q2
$1.43M Buy
44,562
+12,952
+41% +$394K ﹤0.01% 7427
2021
Q1
$1.31M Sell
31,610
-54,888
-63% -$2.96M ﹤0.01% 7445
2020
Q4
$3.95M Buy
86,498
+50,677
+141% +$2.07M ﹤0.01% 4083
2020
Q3
$843K Buy
+35,821
New +$1.2M ﹤0.01% 6343

Other funds holding NNOX

Citadel Advisors's NNOX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nano X Imaging (NNOX) in Q2 2026: 14,119 shares worth $16.4K. The stake represents ﹤0.01% of the portfolio and ranks #13441 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NNOX as recently as Q3 2025.

Citadel Advisors first reported a position in NNOX in Q3 2020 and has held it in 11 quarters since. The position peaked at $3.95M in Q4 2020. 100 funds tracked by Wall St. Rank hold NNOX as of Q2 2026.

  • Citadel Advisors held 14,119 shares of Nano X Imaging worth $16.4K as of Q2 2026.
  • Nano X Imaging was a new Citadel Advisors position in Q2 2026.
  • Nano X Imaging made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13441 holding.
  • Citadel Advisors first reported a position in Nano X Imaging in Q3 2020 and has held it in 11 quarters since.
  • Citadel Advisors's Nano X Imaging position peaked at $3.95M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Nano X Imaging as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.